AlphaGrep UK’s Exelon EXC Stock Holding History

AlphaGrep UK’s Portfolio EXC Stock Details EXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,623	Closed	-$374K	–	797
2026 Q1	$374K	Sell	7,623 -10,025	-57%	-$466K	0.11%	403
2025 Q4	$769K	Buy	+17,648	New	+$805K	0.26%	74

Other funds holding EXC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AlphaGrep UK's EXC Position: Q2 2026 in Review

AlphaGrep UK sold out of Exelon (EXC) in Q2 2026, closing a stake of 7,623 shares — an estimated $374K sold.

AlphaGrep UK first reported a position in EXC in Q4 2025 and held it in 2 quarters. The position peaked at $769K in Q4 2025. 1,230 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

AlphaGrep UK reported no remaining Exelon position as of Q2 2026 after selling out during the quarter.
AlphaGrep UK sold 7,623 Exelon shares in Q2 2026, an estimated $374K.
AlphaGrep UK first reported a position in Exelon in Q4 2025 and held it in 2 quarters.
AlphaGrep UK's Exelon position peaked at $769K in Q4 2025.
1,230 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.